Albumin-bound paclitaxel in solid tumors: clinical development and future directions
Madappa N. Kundranda(The University of Texas MD Anderson Cancer Center), Jiaxin Niu(The University of Texas MD Anderson Cancer Center)
Cited by 253
Related Papers
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243
NBTXR3 Activated by Radiotherapy in Combination With Nivolumab or Pembrolizumab in Patients With Advanced Cancers: A Phase I Trial
|International Journal of Radiation Oncology*Biology*Physics|2021|1